China Healthwise Holdings Limited
Research China Healthwise Holdings Limited (0348.HK) on Bullrun: market cap HKD 67.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0348.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyHKD
- Market capHKD 67.49M
- Financial periodFY2025
- RevenueHKD 99.56M
- Revenue growth-12.3%
- Net income-HKD 2.61M
- Free cash flowHKD 14.96M
- Gross margin33.6%
Valuation Snapshot
latest market cap is HKD 67.49M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 99.56M | -HKD 2.61M | HKD 14.96M | 33.6% | 0 | HKD 9.19M | HKD 106.13M | -HKD 20.99M |
| FY2024 | HKD 113.58M | -HKD 40.28M | HKD 1.01M | 32.9% | -0.05 | HKD 9.70M | HKD 103.74M | -HKD 18.38M |
| FY2023 | HKD 146.32M | -HKD 134.56M | HKD 14.30M | 41.2% | -0.17 | HKD 14.42M | HKD 108.90M | HKD 4.40M |
| FY2022 | HKD 142.06M | -HKD 54.27M | -HKD 28.97M | 37.5% | -0.07 | HKD 16.85M | HKD 109.90M | HKD 138.65M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 67.49M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About China Healthwise Holdings Limited
China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand name.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China Healthwise Holdings Limited's market cap?
China Healthwise Holdings Limited's market capitalization is HKD 67.49M.
What does China Healthwise Holdings Limited do?
China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand name. It is also involved in money lending business; and invests in financial instruments.